Third, although we determined the impact of CYP2C8 polymorphisms on bladder cancer risk, the molecular mechanism of CYP2C8 polymorphisms affecting bladder cancer has not been investigated in this work. The gene discussed is CYP2C8; the disease is urinary bladder carcinoma.